B Braun Drug Patent Portfolio
B Braun owns 2 orange book drugs protected by 3 US patents Given below is the list of B Braun's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11998605 | 22 Jul, 2039 | Active | |
| US9504666 | Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration | 11 Dec, 2033 | Active |
| US8969412 | Use for a composition comprising chloroprocaine HCL, a new composition comprising chloroprocaine HCL and a method for its manufacture | 05 Sep, 2026 | Active |
Latest Legal Activities on B Braun's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of B Braun.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 15 May, 2024 | US9504666 |
|
Correspondence Address Change
Critical
| 10 Nov, 2022 | US8969412 |
|
Correspondence Address Change
Critical
| 09 Nov, 2022 | US8969412 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 17 Aug, 2022 | US8969412 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 14 May, 2020 | US9504666 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 23 Aug, 2018 | US8969412 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 29 Nov, 2016 | US9504666 |
|
Recordation of Patent Grant Mailed
Critical
| 29 Nov, 2016 | US9504666 |
|
Email Notification
Critical
| 10 Nov, 2016 | US9504666 |
|
Issue Notification Mailed
Critical
| 09 Nov, 2016 | US9504666 |
| Dispatch to FDC | 28 Oct, 2016 | US9504666 |
|
Application Is Considered Ready for Issue
Critical
| 28 Oct, 2016 | US9504666 |
|
Issue Fee Payment Verified
Critical
| 25 Oct, 2016 | US9504666 |
|
Issue Fee Payment Received
Critical
| 25 Oct, 2016 | US9504666 |
|
Electronic Review
Critical
| 29 Jul, 2016 | US9504666 |
B Braun's Family Patents
B Braun Drug List
Given below is the complete list of B Braun's drugs and the patents protecting them.
1. Clorotekal
Clorotekal is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9504666 | Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration |
11 Dec, 2033
(7 years from now)
| Active |
| US8969412 | Use for a composition comprising chloroprocaine HCL, a new composition comprising chloroprocaine HCL and a method for its manufacture |
05 Sep, 2026
(7 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Clorotekal's drug page
2. Rocuronium Bromide
Rocuronium Bromide is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11998605 |
22 Jul, 2039
(13 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Rocuronium Bromide's drug page